Indo US Bio-Tech Faces Intense Selling Pressure Amid Significant Price Declines
Indo US Bio-Tech Ltd is experiencing significant selling pressure, marking a trend reversal after five days of gains. Despite outperforming the Sensex recently, the stock has seen substantial declines over the past year and is currently underperforming its sector, indicating a shift in investor confidence.
Indo US Bio-Tech Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced a notable decline of 5.49%, sharply contrasting with the Sensex's modest drop of 0.58%. This marks a trend reversal after five consecutive days of gains, indicating a shift in market sentiment.Over the past week, Indo US Bio-Tech has outperformed the Sensex with a gain of 7.98%, but this recent downturn highlights a troubling pattern. The stock has lost 18.97% over the last three months and 27.87% over the past year, while the Sensex has gained 9.49% during the same period. Year-to-date, Indo US Bio-Tech has plummeted by 47.79%, significantly underperforming the Sensex's 3.64% increase.
The stock's performance today underperformed its sector by 5.82%, with an intraday low of Rs 164.4. Despite being above its 5-day, 20-day, and 50-day moving averages, it remains below the 100-day and 200-day moving averages, suggesting a potential shift in investor confidence. The ongoing selling pressure may be attributed to various market dynamics affecting investor sentiment in the agricultural products sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
